CYTRX CORP 4
4 · CYTRX CORP · Filed Dec 17, 2015
Insider Transaction Report
Form 4
CYTRX CORPCYTR
Wieland Douglas Scott
Sr. VP - Drug Development
Transactions
- Award
Stock Option (right to buy)
2015-12-15+100,000→ 100,000 totalExercise: $2.44Exp: 2025-12-14→ CytRx Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The Stock Option vests monthly for 36 months in equal installments, beginning 15 January 2016, provided Reporting Person remains in continuous employ of issuer.